Abstract
Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
The Natural Products Journal
Title: Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes
Volume: 2 Issue: 1
Author(s): Prabhakar Singh and Syed Ibrahim Rizvi
Affiliation:
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
Abstract: Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Export Options
About this article
Cite this article as:
Singh Prabhakar and Ibrahim Rizvi Syed, Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes, The Natural Products Journal 2012; 2 (1) . https://dx.doi.org/10.2174/2210315511202010069
DOI https://dx.doi.org/10.2174/2210315511202010069 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes
Mini-Reviews in Medicinal Chemistry Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
Current Drug Targets The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations
Current Drug Targets Nicotinamide Phosphoribosyltransferase as a Target in Inflammation- Related Disorders
Current Topics in Medicinal Chemistry Modulation of Apoptosis: New Opportunities for Drug Discovery to Treat Autoimmune Thyroiditis
Recent Patents on Inflammation & Allergy Drug Discovery Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Role of Stem Cells in Muscular Dystrophies
Current Gene Therapy Non-Analgesic Effects of Opioids: Mechanisms and Potential Clinical Relevance of Opioid-Induced Immunodepression
Current Pharmaceutical Design Targeting the Coagulation Factor Fibrinogen for Arthritis Therapy
Current Pharmaceutical Biotechnology Respiratory Tolerance in the Protection Against Asthma
Current Drug Targets - Inflammation & Allergy Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology ADAMTS Proteinases: Potential Therapeutic Targets?
Current Pharmaceutical Biotechnology Cyano Acrylate Polymers in Medical Applications
Recent Patents on Materials Science The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued)